financetom
Business
financetom
/
Business
/
IperionX Gets US Department of Defense Contract; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IperionX Gets US Department of Defense Contract; Shares Rise
Jun 5, 2025 8:50 AM

11:32 AM EDT, 06/05/2025 (MT Newswires) -- IperionX ( IPX ) said Thursday it has received a small business innovation research phase 3 contract from the US Department of Defense to achieve "Low-Cost Domestic Titanium for Defense Applications" in the US.

The contract enables the firm to receive task order funding from the department agencies up to a total of $99 million, it said.

"This award recognizes IperionX's ( IPX ) readiness to deliver strategic titanium components for US defense applications," the firm said.

Shares were up almost 20% in recent trading.

Price: 29.30, Change: +4.88, Percent Change: +19.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Airbus CEO Says 'Not Unlikely' It Could Acquire Portions of Spirit Aerosystems from Boeing Following Merger
Market Chatter: Airbus CEO Says 'Not Unlikely' It Could Acquire Portions of Spirit Aerosystems from Boeing Following Merger
Apr 11, 2024
11:40 AM EDT, 04/11/2024 (MT Newswires) -- Spirit Aerosystems' ( SPR ) assembly facilities in North Carolina and Northern Ireland eventually could become part of Airbus if Boeing ( BA ) is able to complete its proposed acquisition of the airplane components manufacturer, Airbus Chief Executive Guillaume Faury said in a Reuters interview on Thursday. Boeing ( BA ) and...
What's Going On With Candel Therapeutics Stock?
What's Going On With Candel Therapeutics Stock?
Apr 11, 2024
Candel Therapeutics, Inc. ( CADL ) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. The Details: We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled the...
National Bank on Richelieu Hardware's Q1
National Bank on Richelieu Hardware's Q1
Apr 11, 2024
11:39 AM EDT, 04/11/2024 (MT Newswires) -- Richelieu Hardware's ( RHUHF ) Q1/24 revenues, at $406.9 million, was up 1% y/y, driven by a 0.4% organic decline and offset by a 1.4% lift from acquisitions, slightly below consensus of $407.8 million and National Bank's $416.5 million forecast. EBITDA margins contracted 230 bps y/y to 9.9% resulting in $40.4 million in...
Update: CarMax Shares Slump as Fiscal Q4 Results Miss Forecasts
Update: CarMax Shares Slump as Fiscal Q4 Results Miss Forecasts
Apr 11, 2024
11:40 AM EDT, 04/11/2024 (MT Newswires) -- (Updates with latest stock movement in headline and first paragraph) CarMax ( KMX ) shares fell 13% in recent Thursday trading after the company's fiscal Q4 results trailed forecasts by analysts. Earlier, Carmax ( KMX ) reported fiscal Q4 net earnings of $0.32 per diluted share, down from $0.44 a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved